D. Wolff

发表

Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.

G. Lyman, J. Crawford, D. Dale, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study

G. Lyman, J. Crawford, D. Dale, 2015, SpringerPlus.

Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.

J. Griggs, G. Lyman, J. Crawford, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preventing Obesity and Its Consequences: Highlights of RAND Health Research

Arleen F. Brown, Ariane L. Bedimo-Rung, P. Shekelle, 2011 .

Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy

G. Lyman, J. Crawford, M. Poniewierski, 2004 .

Predicting the risk of neutropenic complications and reduced dose intensity in patients with early-stage breast cancer (ESBC): Results from a prospective nationwide registry.

G. Lyman, J. Crawford, E. Culakova, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective validation of a risk model for first cycle neutropenic complications in patients receiving cancer chemotherapy.

G. Lyman, J. Crawford, N. Kuderer, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.

J. Griggs, G. Lyman, J. Crawford, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials.

G. Lyman, N. Kuderer, E. Culakova, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy.

G. Lyman, J. Crawford, M. Poniewierski, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy

G. Lyman, J. Crawford, D. Dale, 2011, Cancer.

Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.

G. Lyman, J. Crawford, D. Dale, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy

G. Lyman, J. Crawford, D. Dale, 2005, Cancer.

Variation in the cost of medications for the treatment of colorectal cancer.

A. Khorana, G. Lyman, L. Cosler, 2008, The American journal of managed care.

Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy

G. Lyman, J. Crawford, D. Dale, 2009, Cancer.

A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy

G. Lyman, J. Crawford, D. Dale, 2005 .

30 A risk model for first cycle neutropenic events in older cancer patients receiving systemic chemotherapy

G. Lyman, J. Crawford, D. Dale, 2006 .

Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy.

G. Lyman, L. Cosler, D. Dale, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose Intensity and Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy.

G. Lyman, J. Crawford, D. Dale, 2005 .

A prediction model for chemotherapy-associated thrombocytopenia in cancer patients.

C. Francis, G. Lyman, J. Crawford, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry.

G. Lyman, J. Crawford, D. Dale, 2005, The journal of supportive oncology.

A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

G. Lyman, J. Crawford, D. Dale, 2007 .

G. Lyman, J. Crawford, D. Dale, 2008 .

Preventing Obesity and Its Consequences

Arleen F. Brown, Ariane L. Bedimo-Rung, P. Shekelle, 2011 .

Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy

G. Lyman, J. Crawford, D. Dale, 2011, Cancer.